Tazemetostat trihydrochloride T15240
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Tazemetostat trihydrochloride is a selective and orally available inhibitor of EZH2 (IC50: 4 nM for rat EZH2). It inhibits the activity of human PRC2-containing wild-type EZH2 (Ki: 2.5 nM). It inhibits EZH2 (IC50s: 11 and 16 nM in peptide assay and nucleo
CAS nr:
1403255-00-4
Purity:
98%
Molecular Weight:
682,12
SMILES:
O=C(C1=CC(C2=CC=C(CN3CCOCC3)C=C2)=CC(N(CC)C4CCOCC4)=C1C)NCC5=C(C)C=C(C)NC5=O.[H]Cl.[H]Cl.[H]Cl
Formula:
C34H47Cl3N4O4
Pathway:
Chromatin/Epigenetic
Target:
Histone Methyltransferase
